A decrease in miR-96-5p and miR-182-5p expression as well as a decrease in the CD138 proportion and Th1/Th2 ratio might be involved in the mechanisms of therapeutic effects of ASCs in C3.MRL-Faslpr/J mice with the SLE phenotype. This evidence concerns the gene SDC1 and systemic lupus erythematosus.